Showing results (2151-2160 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|February 19, 2016
Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- miceChristopher Felix Krombholz, Konrad Aumann, Matthias Kollek, et al.
Haematologica|February 19, 2016
Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID studySung-Eun Lee, Soo Young Choi, Hye-Young Song, et al.
Haematologica|November 28, 2015
Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donorsEsteban Arrieta-Bolaños, Neema P Mayor, Steven G E Marsh, et al.
Haematologica|December 15, 2015
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphomaGuillaume Cartron, Florence Hourcade-Potelleret, Franck Morschhauser, et al.
Haematologica|July 21, 2022
Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosisLilian Varricchio, Eliza B Geer, Fabrizio Martelli, et al.
Haematologica|June 23, 2018
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studiesMara M Epstein, Bernard Rosner, Elizabeth C Breen, et al.
Haematologica|September 15, 2018
Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancyJae-Ho Yoon, Sung-Soo Park, Young-Woo Jeon, et al.
Haematologica|October 4, 2017
Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMTReinhold Munker, Myriam Labopin, Jordi Esteve, et al.
Haematologica|October 4, 2017
Steroid treatment of acute graft-versus-host disease grade I: a randomized trialAndrea Bacigalupo, Giuseppe Milone, Alessandra Cupri, et al.
Haematologica|September 16, 2017
Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cellsLaure Delestré, Hengxiang Cui, Michela Esposito, et al.
Pageof 816